K A Phillips

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?
    K A Phillips
    Samuel Lunenfeld Research Institute and Marvelle Koffler Breast Center, Mt Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada
    J Clin Oncol 17:3653-63. 1999
  2. ncbi request reprint Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2
    K A Phillips
    Department of Medical Oncology and Haematology, Princess Margaret Hospital, Toronto, Ontario, Canada
    Clin Genet 57:376-83. 2000
  3. ncbi request reprint Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer
    K A Phillips
    Department of Haematology, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia
    Australas Radiol 45:200-4. 2001
  4. ncbi request reprint Current perspectives on BRCA1- and BRCA2-associated breast cancers
    K A Phillips
    Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia
    Intern Med J 31:349-56. 2001
  5. ncbi request reprint Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study
    K A Phillips
    Division of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, University of Melbourne Department of Medicine, St Vincent s Hospital, Victoria, NSW, Australia
    Clin Genet 70:198-206. 2006
  6. pmc Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
    R J MacInnis
    Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Melbourne, Australia
    Br J Cancer 109:1296-301. 2013
  7. pmc Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    B E Kiely
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Vic, 8006, Australia
    Fam Cancer 10:505-14. 2011
  8. doi request reprint Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    S L Harvey
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, VIC 8006, Australia
    Breast Cancer Res Treat 130:1057-61. 2011
  9. ncbi request reprint Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy
    C I Scott
    Department of Hematology and Medical Oncology, Familial Cancer Center, Peter MacCallum Cancer Institute, St Andrew s Place, East Melbourne, Victoria, 3002, Australia
    Clin Genet 64:111-21. 2003
  10. ncbi request reprint Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers
    K A Phillips
    Peter MacCallum Cancer Institute, Victoria, Australia
    J Clin Oncol 18:107S-12S. 2000

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?
    K A Phillips
    Samuel Lunenfeld Research Institute and Marvelle Koffler Breast Center, Mt Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada
    J Clin Oncol 17:3653-63. 1999
    ..To review the preclinical and clinical studies relevant to the prognosis and prognostic associations of BRCA1- and BRCA2-associated breast carcinomas, with an emphasis on research methodology...
  2. ncbi request reprint Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2
    K A Phillips
    Department of Medical Oncology and Haematology, Princess Margaret Hospital, Toronto, Ontario, Canada
    Clin Genet 57:376-83. 2000
    ..The focus on altruistic factors and those related to perceived psychological benefits of testing is notable...
  3. ncbi request reprint Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer
    K A Phillips
    Department of Haematology, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia
    Australas Radiol 45:200-4. 2001
    ..Further, methodologically rigorous studies of large numbers of breast cancer patients who carry a mutation in BRCA1 or BRCA2 are required to fully elucidate these issues...
  4. ncbi request reprint Current perspectives on BRCA1- and BRCA2-associated breast cancers
    K A Phillips
    Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia
    Intern Med J 31:349-56. 2001
    ....
  5. ncbi request reprint Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study
    K A Phillips
    Division of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, University of Melbourne Department of Medicine, St Vincent s Hospital, Victoria, NSW, Australia
    Clin Genet 70:198-206. 2006
    ..In this cohort, the minority of mutation carriers utilized risk-reducing surgery or chemoprevention and a substantial minority were not undergoing regular cancer-screening tests...
  6. pmc Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
    R J MacInnis
    Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Melbourne, Australia
    Br J Cancer 109:1296-301. 2013
    ..It is uncertain whether BOADICEA performs adequately for populations outside the United Kingdom...
  7. pmc Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    B E Kiely
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Vic, 8006, Australia
    Fam Cancer 10:505-14. 2011
    ..Additional education of clinicians and consumers is needed to ensure optimal surgery and pathology in these women...
  8. doi request reprint Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    S L Harvey
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, VIC 8006, Australia
    Breast Cancer Res Treat 130:1057-61. 2011
    ..Despite this being the largest prospective cohort to assess this issue, moderately increased breast cancer risk (2-fold) cannot be ruled out...
  9. ncbi request reprint Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy
    C I Scott
    Department of Hematology and Medical Oncology, Familial Cancer Center, Peter MacCallum Cancer Institute, St Andrew s Place, East Melbourne, Victoria, 3002, Australia
    Clin Genet 64:111-21. 2003
    ....
  10. ncbi request reprint Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers
    K A Phillips
    Peter MacCallum Cancer Institute, Victoria, Australia
    J Clin Oncol 18:107S-12S. 2000
    ....
  11. ncbi request reprint Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer
    K M Field
    Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag No 1, A Beckett St, Melbourne, Victoria 8006, Australia
    Eur J Cancer 45:551-60. 2009
    ..Few data exist regarding the use of complementary and alternative medicine (CAM) by unaffected women at high risk of breast cancer...
  12. pmc Morphological predictors of BRCA1 germline mutations in young women with breast cancer
    M C Southey
    Department of Pathology, Genetic Epidemiology Laboratory, Victoria, Carlton, Australia
    Br J Cancer 104:903-9. 2011
    ..We sought an optimal strategy for identifying carriers using family history, breast cancer morphology and hormone receptor status data...